Sapropterin Dipharma Uniunea Europeană - română - EMA (European Medicines Agency)

sapropterin dipharma

dipharma arzneimittel gmbh - diclorhidrat de sapropterină - phenylketonurias - alte medicamente pentru tractul digestiv și metabolism, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

Eucreas Uniunea Europeană - română - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, clorhidrat de metformină - diabetul zaharat, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Uniunea Europeană - română - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, clorhidrat de metformină - diabetul zaharat, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).

Zomarist Uniunea Europeană - română - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptin, clorhidrat de metformină - diabetul zaharat, tip 2 - medicamente utilizate în diabet - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Cufence Uniunea Europeană - română - EMA (European Medicines Agency)

cufence

univar solutions bv - trientine diclorhidrat - degenerarea hepatolenticulară - alte medicamente pentru tractul digestiv și metabolism, - cufence este indicat pentru tratamentul de boala wilson la pacienții cu intoleranță la d-penicilamina terapie, la adulți și copii cu vârsta de 5 ani sau mai în vârstă.